Login to Your Account

Fighting Infections In Silico

Visterra's Antibody Generates Broad Spectrum Antiviral Therapy

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, September 24, 2012

Visterra Inc. made a splash at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy. The company has developed an antibody, VIS410, that neutralizes a broad spectrum of influenza A strains in a preclinical animal model. (See BioWorld Today, Sept. 12, 2012.)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription